HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intracavitary injection of OK-432 for malignant pericardial effusion, a case report.

Abstract
The clinical efficacy of OK-432 has been evaluated favorably when administered for malignant effusion in pleural and peritoneal cavities. It may be effective also in pericardial space in response to inflammation or tumor, i.e., in weep fluid, but there are few reports of the clinical efficacy of a single administration of this agent in this space. We present here a case of spontaneous remission of malignant pericardial effusion after a single injection of OK-432 into the pericardial space.
AuthorsT Nanjo
JournalRadiation medicine (Radiat Med) 1990 Jul-Aug Vol. 8 Issue 4 Pg. 155-8 ISSN: 0288-2043 [Print] Japan
PMID2281151 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Picibanil
Topics
  • Adenocarcinoma (complications, secondary)
  • Heart Neoplasms (complications, secondary)
  • Humans
  • Lung Neoplasms (pathology)
  • Male
  • Middle Aged
  • Pericardial Effusion (etiology, therapy)
  • Picibanil (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: